Atreca, Inc. - 04965G109
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Description is not available for this instrument yet.
Quarter snapshot
Latest / Compare
Q4 2023
· Q3 2023
Value (USD)
Total reported value ($000)
$584K
QoQ value delta ($000)
-$1.038M
(-64.0%)
Implied price effect (QoQ)
-49.87%
Shares
Total shares
4,493,201
QoQ shares delta
-1,762,740
(-28.18%)
Total shares held by funds (by quarter)
Top holders (Q4 2023)
Top 25 only
Full list
Early Q1 2024 data: only 4 institutional holders reported so far. More will appear as funds file with the SEC.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| BAKER BROS. ADVISORS LP | 287 | 2,177,499 | 0.0% |
| VANGUARD GROUP INC | 120 | 909,300 | 0.0% |
| RENAISSANCE TECHNOLOGIES LLC | 47 | 356,024 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 39 | 295,471 | 0.0% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 13 | 104,712 | 0.0% |
| Ensign Peak Advisors, Inc | 13 | 105,283 | 0.0% |
| MILLENNIUM MANAGEMENT LLC | 12 | 91,447 | 0.0% |
| STATE STREET CORP | 11 | 89,320 | 0.0% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 9 | 75,000 | 0.0% |
| NORTHERN TRUST CORP | 7 | 59,168 | 0.0% |
| BARCLAYS PLC | 6 | 47,487 | 0.0% |
| GOLDMAN SACHS GROUP INC | 6 | 45,831 | 0.0% |
| FMR LLC | 4 | 33,331 | 0.0% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 3 | 22,959 | 0.0% |
| Bank of New York Mellon Corp | 2 | 15,158 | 0.0% |
| XTX Topco Ltd | 2 | 21,133 | 0.0% |
| JANE STREET GROUP, LLC | 1 | 11,403 | 0.0% |
| UBS Group AG | 1 | 12,210 | 0.0% |
| Parallel Advisors, LLC | 1 | 8,114 | 0.0% |
| JPMORGAN CHASE & CO | 0 | 23 | 0.0% |
| BANK OF AMERICA CORP /DE/ | 0 | 575 | 0.0% |
| WELLS FARGO & COMPANY/MN | 0 | 2,251 | 0.0% |
| MORGAN STANLEY | 0 | 4,556 | 0.0% |
| ROYAL BANK OF CANADA | 0 | 770 | 0.0% |
| SIMPLEX TRADING, LLC | 0 | 100 | 0.0% |